Acadian Asset Management
NAGE

Acadian Asset Management’s Niagen Bioscience NAGE Stock Holding History

Acadian Asset Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-547,261
Closed -$5.1M – 2160
2025
Q3 		$5.1M Buy
547,261
+18,702
+4% +$189K 0.01% 638
2025
Q2 		$7.61M Buy
528,559
+395,294
+297% +$3.9M 0.02% 487
2025
Q1 		$918K Buy
+133,265
New +$837K ﹤0.01% 957
2024
Q4 		– Sell
-10,430
Closed -$38K – 2251
2024
Q3 		$38K Sell
10,430
-2,835
-21% -$8.92K ﹤0.01% 1881
2024
Q2 		$35K Sell
13,265
-6,196
-32% -$20.7K ﹤0.01% 1637
2024
Q1 		$67K Buy
+19,461
New +$36K ﹤0.01% 1347
2023
Q1 		– Sell
-15,831
Closed -$26K – 2009
2022
Q4 		$26K Buy
+15,831
New +$25.1K ﹤0.01% 1679

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management's NAGE Position: Q4 2025 in Review

Acadian Asset Management sold out of Niagen Bioscience (NAGE) in Q4 2025, closing a stake of 547,261 shares — an estimated $5.1M sold.

Acadian Asset Management first reported a position in NAGE in Q4 2022 and held it in 7 quarters. The position peaked at $7.61M in Q2 2025. 169 funds tracked by Wall St. Rank hold NAGE as of Q4 2025.

  • Acadian Asset Management reported no remaining Niagen Bioscience position as of Q4 2025 after selling out during the quarter.
  • Acadian Asset Management sold 547,261 Niagen Bioscience shares in Q4 2025, an estimated $5.1M.
  • Acadian Asset Management first reported a position in Niagen Bioscience in Q4 2022 and held it in 7 quarters.
  • Acadian Asset Management's Niagen Bioscience position peaked at $7.61M in Q2 2025.
  • 169 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2025.

Based on Acadian Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.